XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Sep. 30, 2016
Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (6,909,566) $ 3,057,920
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Gain on sale of marketable securities (572,945)
Gain on sale of property and equipment 5,381
Change in accounts receivable and inventory reserves 2,483,947 (61,616)
Depreciation, amortization and impairment 2,343,273 371,121
Change in cash surrender value of life insurance (12,373) (14,575)
Warranty reserve. (28,250) (82,995)
Other-than-temporary impairment loss on investments 1,502,239 0
Change in operating assets and liabilities:    
Accounts receivable (8,362,763) (8,327,227)
Notes receivable and other non-trade receivables (1,560,740) 111,274
Inventories (6,084,943) (3,212,440)
Prepaid expenses and other assets 487,462 115,057
Accounts payable 3,004,536 3,017,840
Accrued expenses 797,290 (58,760)
Income taxes payable/ receivable (397,331) 1,098,013
Non-current liabilities (442,874)
Total adjustments (6,843,472) (7,038,927)
Net cash used in operating activities (13,753,038) (3,981,007)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of marketable securities (2,505,520) (1,863,621)
Proceeds from sale of marketable securities 5,254,087
Net cash flow from business combination (4,033,367)
Capital expenditures (911,040) (513,433)
Proceeds from sale of property and equipment 10,745 19,163
Increase in restricted cash (3,411) (3,316)
Net cash used in investing activities (2,188,506) (2,361,207)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from line of credit 40,368,017 14,291,273
Payment on line of credit (19,606,842) (17,909,633)
Repurchase of common stock (7,917,009)
Net cash provided by (used in) financing activities 12,795,216 (3,618,360)
Effect of foreign currency exchange rates on cash and cash equivalents (7,387)
NET DECREASE IN CASH AND CASH EQUIVALENTS (3,153,715) (9,960,574)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 5,345,455 [1] 13,388,767
CASH AND CASH EQUIVALENTS AT END OF PERIOD 2,191,740 3,428,193
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING ACTIVITIES:    
Finished goods inventory transferred to equipment leased to customers 321,345 1,143,635
Change in fair value of marketable securities (1,022,791) (866,430)
SUPPLEMENTAL DISCLOSURE OF INVESTING ACTIVITIES:    
Non-controlling interest in acquired business 1,072,161
Acquired business earnout contract 2,900,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest 61,767 45,118
Income taxes 400,331 267,134
Delphax [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payment on line of credit (48,950)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD [2],[3] 249,528  
CASH AND CASH EQUIVALENTS AT END OF PERIOD [2] $ 166,593  
[1] Derived from audited consolidated financial statements
[2] Amounts related to Delphax as of September 30, 2016, and March 31, 2016, respectively.
[3] Derived from audited consolidated financial statements